0001493152-24-051820.txt : 20241223 0001493152-24-051820.hdr.sgml : 20241223 20241223160534 ACCESSION NUMBER: 0001493152-24-051820 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241223 DATE AS OF CHANGE: 20241223 EFFECTIVENESS DATE: 20241223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sonnet BioTherapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001106838 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 522102141 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-533167 FILM NUMBER: 241573611 BUSINESS ADDRESS: STREET 1: 100 OVERLOOK CENTER STREET 2: SUITE 102 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-375-2227 MAIL ADDRESS: STREET 1: 100 OVERLOOK CENTER STREET 2: SUITE 102 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: Chanticleer Holdings, Inc. DATE OF NAME CHANGE: 20050510 FORMER COMPANY: FORMER CONFORMED NAME: TULVINE SYSTEMS INC DATE OF NAME CHANGE: 20000214 D 1 primary_doc.xml X0708 D LIVE 0001106838 Sonnet BioTherapeutics Holdings, Inc. 100 OVERLOOK CETNER SUITE 102 PRINCETON NJ NEW JERSEY 08540 609-375-2227 DELAWARE Tulvine Systems Inc Chanticleer Holdings, Inc. TULVINE SYSTEMS INC Corporation true Pankaj Mohan 100 Overlook Center Suite 102 Princeton NJ NEW JERSEY 08540 Executive Officer Director Jay Cross 100 Overlook Center Suite 102 Princeton NJ NEW JERSEY 08540 Executive Officer John K. Cini 100 Overlook Center Suite 102 Princeton NJ NEW JERSEY 08540 Executive Officer Susan Dexter 100 Overlook Center Suite 102 Princeton NJ NEW JERSEY 08540 Executive Officer Richard Kenny 100 Overlook Center Suite 102 Princeton NJ NEW JERSEY 08540 Executive Officer Nailesh Bhatt 100 Overlook Center Suite 102 Princeton NJ NEW JERSEY 08540 Director Albert Dyrness 100 Overlook Center Suite 102 Princeton NJ NEW JERSEY 08540 Director Donald Griffith 100 Overlook Center Suite 102 Princeton NJ NEW JERSEY 08540 Director Raghu Rao 100 Overlook Center Suite 102 Princeton NJ NEW JERSEY 08540 Director Lori McNeil 100 Overlook Center Suite 102 Princeton NJ NEW JERSEY 08540 Director Biotechnology Decline to Disclose 06b false 2024-12-10 false true true true false 0 Chardan Capital Markets, LLC 000120128 None None One Pennsylvania Plaza Suite 4800 NEW YORK NY NEW YORK 10119 All States false 3918000 3918000 0 false 4 378686 0 0 true The Company intends to use the net proceeds for research and development, including clinical trials, working capital and general corporate purposes. false Sonnet BioTherapeutics Holdings, Inc. /s/ Jay Cross Jay Cross Chief Financial Officer 2024-12-23